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1199-95 In-Vivo Measurement of Coronary Anglotension- 
Converting Enzyme (ACE) Activity in Humans 
Cezar Staniloae. Richard Gallo, Ihor Dyrda, Gilbert Gosselin, Jacques Lesperance, 
James W. Ryan, Andreas J. Schwab, Andr~ Simard, Jocelyn Dupuis, Montreal Heart 
Institute, Montreal, Quebec, Canada. 
The relationship between atherosclerosis and ACE activity is unclear.We tried to estab- 
lish whether the endothelium bound coronary ACE activity correlates with coronary ath- 
erosclerotic burden. 
Methods. A single bolus indicator-dilution experiment was performed in 10 patients. 
Trace amounts of the specific ACE substrate 3H-benzoyI-Phe-Ala-Pro (3H-BPAP) and of 
the myocardial interstitial space reference 14C-sucrose were injected in the left main cor- 
onary artery. Serial samples were obtained from the coronary sinus. Plasma concentra- 
tions of residual substrate and end-product (3H-BP) were measured. Mean transit time of 
each tracer and myocardial plasma flow (~) were determined. The curves were modelled 
to compute the rate constant for 3H-BPAP hydrolysis by ACE (Kh). Coronary angiograms 
were scored for atherosclerotic burden according to 2 previously described techniques to 
obtain the plaque area index (PAl)and Sullivan's extent score (SES). Spearman correla- 
tion test was used to calculate p values. 
Results. The atherosclerotic burden extent scores correlated well with each other (r= 
0.82; p=0.002), There was a weak correlation between K h and measures of atheroscle- 
rotic burden (r =0.4; p=0.22). 
Conclusion. The indicator-dilution technique is a safe tool to quantify endothelium bound 
coronary ACE activity. The weak correlation between endothelium bound coronary ACE 
activity and extent scores suggests that tissue ACE may play a more important patho- 
physiologic role in the disease process, 
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• (e "1) Kh (s-l) PAl SES 
1 0.04 1.22 0.53 26.50 
2 0.09 0.50 2.96 66.97 
3 0.05 1.11 4.18 36.13 
4 0.80 0.95 5.75 49.21 
5 0.05 0.38 0.27 4.94 
6 0.08 0.81 5.03 36.50 
7 0.05 0,63 7.27 54.08 
8 0.07 0.02 3.1 64.98 
9 0.07 0.70 O.0 0.0 
10 0.08 0.84 0.O 0.0 
1199-96 BNP Preserves Endothelial Cell Integrity: Modulation by 
Atheroaclerosie and Vasopeptidase Inhibition 
Amy M. Larsen. Sharon M. Sandberg, Hanna Leskinen, Alessandro Cataliotti, John C. 
Burnett, Jr., Mayo Clinic, Rochester, Minnesota. 
Background: BNP is the most potent natriuretic psptide and mediates its actions by 
receptors that activate cGMP. We defined anti-atherogenic actions of BNP through pres- 
ervation of endothelial cell (EC) impermeability to macromolecules. As atherosclerosis 
involves damaged EC allowing penetration of oxidized LDL leading to atheroma forma- 
tion, we extended our studies to an animal model of atherosclerosis. We looked at the 
ability of omapatrilat (OMA), a vasopeptidase inhibitor, to preserve EC impermeability 
contributing to inhibition of atheroma formation based on the actions of OMA, namely co- 
inhibition of the enzymes neutral endopeptidase (NEP), which degrades BNP, and angio- 
tensin converting enzyme (ACE). Methods: EC permeability was determined by 1131 
albumin flux in cultured HAEC in the presence and absence of thrombin stimulation. 
cGMP generation was determined by RIA. Aortic EC permeability in vivo was determined 
in normal and atherogenic animals by determining transvascular flux of Evans Blue Dye 
(EBD) bound albumin while atheroma formation was determined in harvested aortas by 
Oil Red O staining. Studies were performed in a rabbit model of atherosclerosis after 8 
weeks of 1% cholesterol diet (n=5) or 1% cholesterol diet plus OMA 12mg/kg/day (n=4). 
Results: In cultured EC, BNP prevented thrombin induced increases in EC permeability 
(Control:17,200±201; Thrombin: 24,840±380, p<0.05; Thrombin + BNP: 14,750¢180 
cpm). BNP also markedly increased cGMP generation (p<0.05) that was reduced by HS- 
142-1 (0.1 mg/ml), a NP receptor antagonist. In vivo, oral OMA reduced the area of aortic 
EC permeability (5.6%± 2.9) as compared to untreated hypercholestarolemic rabbits 
(18%±2%, p< 0.001) as determined by EBD. OMA also reduced the area of plaque from 
58.8% in untreated to 23.6% (p<0.05) with no difference in plasma cholesterol (OMA: 
2177± 97 vs. untreated: 2047± 267 mmol/L). Conclusion: We report that BNP maintains 
EC impermeability to macromolecules in response to injury by thrombin with activation of 
cGMP. in addition, we report that long-term oral inhibition of NEP and ACE also main- 
tains EC impermeability while atlenuating atheroma formation independent of reductions 
in serum cholesterol. 
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1200-71 Character is t ics  of  Coronary Resistance Artery Function 
in a Biracial Cohort With Severe Left Ventricular 
Hypertrophy 
J~n L. Houohton, Mikhail T, Torosoff, Albany Medica/Col/ege, Albany, New York. 
Background: Left ventricular hypertrophy (LVH) affects coronary autoregulation through 
direct effects on vascular endothelium and smooth muscle cells and secondarily through 
increased metabolic demand and altered diastolic relaxation. Subjects with coronary 
artery disease and LVH have a markedly worsened prognosis despite appropriate medi- 
cal therapy. The purpose of this study was to examine the impact of severe LVH on rest- 
ing and hyperemic resistance artery function in a biracial healthy cohort without 
angiographic coronary artery disease. 
Methods: Study subjects were selected based on the presence of severe LVH defined 
as indexed mass _> 50% above normal using allometric mass criteria. Resistance artery 
endothelium-dependent and -independent characteristics were tested using the intracor- 
onary Doppler wire and coronary angiography for measurement of coronary blood flow 
(CBF) during infusions of intracoronary adenosine and acetylcholine (ACh). Study group 
findings were contrasted with those of similar subjects having mild to moderate LVH 
defined as indexed mass < 50% above normal and with a group having normal LV mass. 
Results: Of 30 subjects with severe LVH, 11 were Caucasians (C) and 19 African Amer- 
icans (AA). The comparison LVH group of 115 subjects consisted of 65 C and 50 AA. The 
normal LV mass group consisted of 56 C and 24 AA. Indexed LV mass and age were 
greater among study subjects (92 _+ 2 vs 60 -+ 1 vs 39 ,+ 1 gm/m 2,7 and 54 ± 2 vs 49 _+ 1 
vs 46 _+ 1 yrs). Baseline CBF was markedly increased in the study group (201 ± 52 vs 116 
,+ 6 vs 93 _+ 5 ml/min, p<0.003). Ejection fraction (64 ± 4 vs 67 ,+ 5 vs 64 _+ 2%) was simi- 
lar. Body mass index (34 _+ 1 vs 33 ,+ 1 vs 28 _+ 1 g/m s) and epicardial dilation in response 
to peak ACh infusion ( -0.8 _+ 2 vs -1.7 ± 1 vs 3 ,+ 2 %) were similar among the LVH 
groups. Peak CBF responses to ACh and adenosine were depressed among study sub- 
jects ( 93 ,+ 14 vs 133 -+ 10 vs 196 + 16 % increase, p<0.07 and 130 + 11 vs 188 ,+ 7 vs 
205 ,+ 9 %, p<0.0002). 
Conclusions: Among subjects with severe LVH, adenosine responses are severely 
depressed while ACh responses are markedly depressed even in the setting of mild LVH. 
Severe LVH is typified by marked depression in both metabolic and cellular governance 
of coronary autoregulation. 
1200-72 Effect o f  Acute  Atr ial  Fibrillation on Coronary 
Circulation 
Panos E. Vardas. George E, Kochiadakis, Emmanuel I. Skalidis, Nikos E. Igoumenidis, 
Michail D. Kaleboubas, Konstantinos E. Vardakis, Stavros I. Chrysostomakis, Michail I. 
Hamilos, Cardiology DpL, Herak/ion University Hospital, Herak/ion Crete, Greece. 
Background: The purpose of this study was to assess the effect of experimentally 
induced AF on coronary circulation in humans. 
Methods: In 8 conscious patients (5 men, mean age 45±9) with normal coronary vessels, 
baseline and hyperemia, blood pressure and Doppler phasic coronary flow velocity 
(using an 0.014" intracoronary Doppler flow wire), were measured, during a) sinus 
rhythm, b) AF induced by rapid right atrial pacing, and c) atrial tachycardia (AT) induced 
by atrial pacing at identical heart rate. Volumetric flow rate corresponds to the product of 
total flow velocity integral, heart rate and cross-sectional area (CSA) of the left descend- 
ing artery at the tip of the wire. Coronary flow reserve (CFR) corresponds to the ratio of 
the coronary flow measured during maximal hyperemia to that recorded at baseline. 
Results: The induction of AF caused a significant increase in heart rate from 74±7 to 
130±16 bpm, a non-significant decrease in mean blood pressure and a significant 
increase in rate-pressure product (RPP) from 7039±911 to 12281±1645 bpm x mmHg. 
For the coronary circulation variables, the induction of AF caused a significant increase in 
CSA from 0.09±0.04 to 0.10±0.04 mm2, a significant increase in coronary blood flow 
from 92±54 to 157±94 ml/min and a significant decrease in CFR from 4.83±1.38 to 
2.44±0.58. The induction of AT caused a significantly greater increase in coronary blood 
flow than did acute AF (p<0.05) and a smaller reduction in CFR (p<0.005), while the 
increases in RPP and CSA were similar to during AE 
Conclusion: Human coronary vessels dilate in response to acute AF, resulting in an 
increase in coronary blood flow. The fact that this latter increase is smaller than that dur- 
ing AT at a similar heart rate, combined with the fact that the RPP is increased to the 
same degree, suggests that factors such as the lack of atrial contraction and the irregu- 
larity of atrial rhythm prevent the coronary flow increasing to the extent required by the 
needs of the myocardium. This may have deleterious consequences in patients with cor- 
onary artery disease, causing or worsening myocardial ischaemia to a greater degree 
than would an elevated heart rate alone. 
